Trials / Completed
CompletedNCT02770131
Chart Review of Repatha® in Subjects With Hyperlipidaemia
Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,986 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Review of clinical characteristics of patients who are prescribed Repatha® and how their treatment is managed.
Conditions
Timeline
- Start date
- 2016-05-04
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2016-05-12
- Last updated
- 2024-06-06
Locations
183 sites across 12 countries: Austria, Belgium, Bulgaria, Czechia, Germany, Greece, Italy, Portugal, Slovakia, Spain, Sweden, Switzerland
Source: ClinicalTrials.gov record NCT02770131. Inclusion in this directory is not an endorsement.